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Tumorigenesistumorigenesis and cellular transformation is intimately entwined with the
development of modern molecular biology. Because SV40 and other viruses have small genomes and are
relatively easy to manipulate in the laboratory, they offered tractable systems for molecular analysis. Thus,
many of the early efforts to understand how eukaryotes replicate their DNA, regulate expression of their
genes, and translate mRNA were focused on viral systems. The discovery that SV40 induces tumors in certain
laboratory animals and transforms many types of cultured cells offered the ﬁrst opportunity to explore the
molecular basis for cancer. The goal of this article is to highlight some of the experiments that have led to our
current view of SV40-induced transformation and to provide some context as to how they contributed to
basic research in molecular biology and to our understanding of cancer.
© 2008 Elsevier Inc. All rights reserved.This is certainly not a history of SV40 and transformation. I am too
young to either remember anything that can be called history, or to
have the perspective necessary to place events in a historical context.
Rather this is an attempt to understand how present day models of
transformation and tumorigenesis emerged, and to highlight the role
SV40 plays in the continuing development of these concepts. Hope-
fully this process will display gaps and weak points in current theory
and thus help formulate the next generation of hypotheses and
experiments.
Most major advances in our understanding of biology are the
consequence of the development of new experimental methods. The
driving force behind the developmentof newmethodologies is the need
to break through barriers that prevent scientists from satisfying their
curiosities. This was certainly true in the 1960's when tumor viruses
emerged as important experimental tools. Many of the most urgent
questions of the day stemmed from a desire to understand cell biology.
The fundamental questions were how do eukaryotes replicate their
DNA, regulate gene expression, translatemRNAand synthesize proteins.
Howdo cells knowwhen to divide andwhen to remain quiescent? How
is differentiation effected? What controls development? Still other
questions of the daywere disease focused.Howdoes cancer arise?What
causes birth defects? How can we prevent epidemics?
By 1960 the value of model systems in the discovery of
fundamental molecular mechanisms was clearly established. The
bacteriophages were extensively studied and proved to be particularly
powerful models. Small, tractable genetic systems that are easy to
grow and manipulate in the laboratory, bacteriophages allowed
genetics and molecular biology to be combined, and this proved toll rights reserved.be a fruitful marriage. This lesson was not lost on animal virologists.
SV40 became a focus of study because it could be easily propagated in
the laboratory, and because it formed well-deﬁned plaques. The viral
life cycle of approximately 4 days was short enough for practical
experimental manipulation. Because it had such a small genome it
was assumed that most viral functions (replication of viral DNA,
expression of viral genes, assembly and release of progeny virions)
would be carried out by cellular components. Furthermore, since SV40
induced tumors and transformed cells it offered one of the ﬁrst
molecular windows on cancer. Thus, understand the virus, and
understand the cell.
Transformation and tumorigenicity
The ability to grow cells in culture drove major advances in cancer
biologyand virology. Viruses could be propagated in culture, free of the
adaptive immune system, allowing genetic screens to identify viral
genes, and provided fodder for the study of the molecular events
occurring during infection such as nucleic acid replication, gene
expression, and virion assembly. Furthermore, cell culture systems
allowed the study of the effects of viral infection on cell biology, aswell
as the identiﬁcation of the viral genes responsible for speciﬁc effects.
In cancer research, cultures of tumor-derived cells allowed the
study of cancer cell biology. However, two important elements were
missing, andwithout them the full promise of cell culture could not be
fulﬁlled. First was the ability to compare the biology of cancer cell
lines to that of their normal counterparts. Cancer cells were hard
enough to establish in culture, and cells from noncancerous tissue
remained viable for a limited number of passages at best. More
importantly, the noncancerous cells that did culture were not of the
same origin as the cultured tumor cell lines, making a comparison of
limited value. This remains a vexing issue in cancer research today.
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cell culture.
The link between animal cancer models and cell culture systems
was provided by a landmark paper published by W. R. Earle and
colleagues in 1943 (Earle et al., 1943b). In a series of carefully
documented experiments, they showed that noncancerous cells
cultured in the presence of methylcholanthrene, an agent known to
induce tumors in animals, gradually “transformed” from a ﬁbroblastic
appearance to a more epithelial morphology. Furthermore, the
“transformed” cells were tumorigenic when injected into mice
(Earle et al., 1943a). Thus, the properties of transformed cells could
be compared directly to the parental culture from which they were
derived.
However, there was still an issue with these types of experiments.
The primary cultures used in these experiments contained a mixture
of different cell types. The gradual transformation observed by Earle
most likely resulted from the overgrowth of the culture with the
descendents of a small number (perhaps just one) of cells that
acquired oncogenic mutations as a result of the treatment with
methylcholanthrene. Thus, it was impossible to know the representa-
tion of that particular cell-type in the culture. If the transformed cells
that overgrow the culture were derived from a minority cell-type in
the population, then the utility of comparing the properties of the
transformed cells with the parental culture would be limited. A
solution to this issuewas provided by the development of methods for
the isolation and culture of single cells (Sanford et al., 1948).
The development of mixed and clonal cultures of normal cells and
the study of their properties led to the development of in vitro assays
for transformation. For example, it was found that cells derived from
skin or muscle exhibit contact inhibition of growth and movement in
culture (Abercrombie and Heaysman,1954). The observation that cells
infected with Rous sarcoma virus do not growth-arrest or cease
movement upon contact was the ﬁrst evidence of in vitro transforma-
tion by the oncogenic retroviruses (Groupe and Manaker, 1956; Lo et
al., 1955). The dense focus assay, which is widely used to assess
oncogenic activity, was subsequently developed as a quantitative
measure of in vitro transformation (Temin and Rubin, 1958). This assay
depends on the ability of transformed cells to escape contact-
mediated growth arrest and thus to continue to proliferate in the
presence of neighboring growth-arrested normal cells. The result is
the appearance of dense foci of multilayered cells growing on top of
the monolayer of normal cells. Since each focus is the clonal
outgrowth of a single transformed cell, the frequency of transforma-
tion can be determined under various conditions. Loss of contact
inhibition and the ability to form dense foci correlate with
tumorigenicity (Aaronson and Todaro, 1968).
Following the development of the dense focus assay, several other
methods were developed to distinguish transformed and normal cells.
These include anchorage independent growth, in which cells are
suspended in dilute agarose or methocel so that they cannot interact
with a surface (Macpherson and Montagnier, 1964). Many trans-
formed cells growth-arrest under these conditions, although theymay
remain viable as single cells for weeks. In contrast, some transformed
cells continue to proliferate and can be visualized as ball-like clusters
under a microscope. Again, tumorigenicity is linked to anchorage
independent growth (Shin et al., 1975). Another commonly used assay
for transformation depends on the ability of transformed cells to
survive and continue to proliferate in the absence of serum. Most cells
are cultured in a rich basal medium supplemented by serum. Normal
cells growth arrest and/or die in the absence of serum, while many
types of transformed cells grow independent of serum. For example,
SV40-transformed cells grow in the absence of serum (Smith et al.,
1971). A more targeted form of this approach utilizes deﬁned, serum-
free medium. Some nontransformed cells proliferate in deﬁned
medium, supplemented with puriﬁed growth factors rather than
serum. In the absence of an essential growth factor, the cells growth-arrest and undergo apoptosis. Transformed cells can be detected as
those that bypass the requirement for an essential growth factor
(Chiang et al., 1985).
Murine polyomavirus was shown to induce cell transformation in
1959 (Dawe and Law, 1959). Furthermore, murine polyomavirus-
transformed cells are tumorigenic (Vogt and Dulbecco, 1960). Thus, by
1960 the reﬁnement of cell culture techniques and studies of the
biology of the oncogenic retroviruses and of murine polyomavirus set
the stage for the in vitro studies of cancer. Three very different entities –
chemical carcinogens, retroviruses and murine polyomavirus – were
shown to share two common properties. Each induces tumors in
animals, and each induces the transformation of cultured cells. At this
point in time it was not clear whether transformation was induced by
a single molecular action that then pleiotropically resulted in the
simultaneous acquisition of the multiple properties of transformed
cells, or if transformation resulted from multiple independent events.
Viruses appeared to offer the most direct path to the answer, and the
tumor viruses came under intense study.
SV40 induces tumors in laboratory animals and transforms cells in
culture
The discovery of SV40 and the development of a robust plaque
assay for the virus introduced a new model-transforming virus to the
arena (Stinebaugh and Melnick, 1962; Sweet and Hilleman, 1960).
SV40 was shown to induce tumors in newborn hamsters and was
conﬁrmed as a DNA tumor virus (Ashkenazi and Melnick, 1963; Black
and Rowe, 1964; Eddy et al., 1961; Gerber and Kirschstein, 1962;
Kirschstein and Gerber, 1962; Rabson and Kirschstein, 1962; Rabson et
al., 1962). Furthermore, SV40 was shown to induce transformation of
many different types of cultured cells, including both rodent and
human cells (Black and Rowe, 1963; Black et al., 1963; Girardi et al.,
1965; Jensen et al., 1963; Koprowski et al., 1962, 1963; Moyer et al.,
1964; Ponten et al., 1963; Shein and Enders, 1962; Todaro and Green,
1964,1966; Todaro et al., 1963,1964,1966). These early studies of SV40
transformation were greatly aided by the development of the ﬁrst
untransformed postcrisis cell line, 3T3 cells (Todaro and Green, 1963).
The development of untransformed established cell lines allowed
the characterization of events following viral infection leading to
transformation. Similarly, the infection of permissive cells with SV40
was shown to lead to a synchronous program that could be monitored
with the emerging molecular techniques of the day. Typically
productive infection was studied in one of several established African
green monkey kidney cell lines, such as BSC or CV1. In these cells, the
infectious cycle takes 3–4 days and results in cell death and the
production of about 300 infectious progeny virions per infected cell.
In contrast, SV40 transformation was studied in rodent cell lines,
such as the established mouse cell line, 3T3 (Todaro and Green, 1963).
Rodent cells are nonpermissive for SV40 productive infection, and
thus no progeny virions are produced when these cells are infected.
However, viral attachment, penetration and uncoating proceed
normally in these cells and the early viral proteins are expressed.
Infection is blocked because viral DNA replication and late gene
expression do not occur. In fact, within a few days following a high
multiplicity infection of mouse or rat cells with either polyomavirus or
SV40, the entire cell population acquires a transformed morphology
(May et al., 1971; Smith et al., 1970, 1971; Stoker, 1968). This is termed
abortive transformation, because the phenotype lasts for a few days
before cells resume a normal untransformed appearance. Stable
transformants emerge from this population with a low but measur-
able frequency, about one cell in every thousand converts to a stable
transformed phenotype. However, these rare stable transformants are
easily detected because after a few days of culture, their clonal
descendants overgrow the monolayer to form dense foci.
Infection with either SV40 or polyomavirus results in increased
synthesis of cellular RNAs and proteins (Frearson et al., 1966; Kit et al.,
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Robbins, 1970). Furthermore, infection of either permissive or
nonpermissive cells with these viruses stimulates quiescent cells to
undergo several rounds of DNA synthesis (Gershon et al., 1965, 1966;
Hatanaka and Dulbecco, 1966; Henry et al., 1966; Kit et al., 1967a;
Winocour et al., 1965).
By the early 1970s, these observations had coalesced to a model in
which an SV40-encoded protein(s) induced quiescent cells to increase
transcription and synthesize DNA in order to use the cell machinery to
carry out viral infection. It was reasoned that the small genome size of
SV40 and polyomavirus precluded them from encoding their own
DNA polymerase or other proteins needed to replicate viral DNA.
Furthermore, the large amount of viral DNA to be replicated (about
100,000 progeny DNA molecules/cell) required the increased synth-
esis of nucleotides, and thus increased amounts of the enzymes
involved in their production.
The A gene of SV40 encodes large tumor antigen
SV40-induced tumors that were transplanted into fresh syngeneic
hosts were rejected and cleared. The antigen that induced this
rejection was termed tumor speciﬁc transplantation antigen or tsta
(Defendi, 1963; Khera et al., 1963; Koch and Sabin, 1963). While it was
known that tsta was only detectable in SV40-transformed or infected
cells, it was not clear whether the antigen was virus-encoded, or if it
was a host antigen that was unmasked by infection or transformation.
Similarly, serum from tumor bearing hamsters or mice was used to
detect an antigen (tumor antigen) induced by SV40 infection or
transformation (Rapp et al., 1964). Such sera immunoprecipitated a
protein of 90–100 kDa from 35S-labelled cellular extracts. However,
again it was not known whether this was a virus-encoded or host-
encoded antigen. Tumor antigen was shown to be expressed within
the ﬁrst few hours following SV40 infection, prior to the replication of
viral DNA and the synthesis of the viral capsid proteins: VP1, VP2, and
VP3. Furthermore, unlike the capsid proteins, tumor antigen was
expressed during the abortive infection of rodent cells.
Because SV40 grows well in culture and forms well-deﬁned
plaques it offered a tractable genetic system and a number of groups
isolated temperature-sensitive viral mutants (Ishikawa and Aizawa,
1973; Kimura and Dulbecco, 1972; Robb and Martin, 1972; Robb et al.,
1974; Rothschild and Lockwood, 1976; Tegtmeyer et al., 1970;
Tegtmeyer and Ozer, 1971; Tevethia and Ripper, 1977; Yamaguchi
and Kuchino, 1975). These mutants fell into four genetic complemen-
tation groups. Temperature-shift experiments established that groups
B, C, and D replicated viral DNA but were defective for late-viral
functions, while A mutants appeared to affect an early viral function
and were defective for viral DNA replication at the nonpermissive
temperature.
The discovery of restriction enzymes and their application to SV40
resulted in the ﬁrst physical map of any DNA molecule (Danna and
Nathans, 1971). This was especially valuable in these years prior to
DNA sequencing. First, a physical map allowed all of the SV40
temperature-sensitive mutants to be physically located on the viral
DNA (Lai and Nathans, 1974b; Lai and Nathans, 1975). DNA fragments
could be isolated from speciﬁc locations on the viral DNA and used as
probes in the newly developed Southern and Northern hybridization
methods. Finally, deletion mutations could be generated in vitro by
speciﬁcally excising DNA fragments from the viral genome (Lai and
Nathans, 1974a).
A beautiful early application of in vitromutagenesis demonstrated
unambiguously that SV40 tumor antigen (T antigen) is virus encoded
(Rundell et al., 1977). While wild-type SV40 DNA induced a T antigen
that was detected as a 94 kDa protein following immunoprecipitation
and SDS-gel electrophoresis, dl1001, a deletionmutant inwhich a DNA
fragment was excised from the A gene, produced a 33 kDa T antigen.
This was consistent with a series of other experiments in whichrestriction fragments containing the early promoter and A gene were
microinjected into cells and shown to produce T antigen (Graessmann
and Graessman, 1976; Graessmann et al., 1975), or in which puriﬁed A
gene protein was microinjected into cells and shown to produce a
protein that reacted with anti-tumor serum (Tjian et al., 1978). Similar
approaches established that T antigen is tsta (Chang et al., 1979). Later
experiments showed that cytotoxic lymphocytes (CTLs) select for T
antigen variants in transformed cells (Lill et al., 1992).
SV40-transformed cells contain integrated viral DNA
SV40-transformed cell lines continue to express T antigen, and
stably display the hallmarks of transformation through many
generations. How is the T antigen gene passed from a dividing cell
to its daughter? One explanation was offered by studies of the
temperate bacteriophage, lambda. During lysogeny lambda integrates
at a speciﬁc location, both with respect to the E. coli chromosome, and
the lambda genome. Did SV40 DNA integrate into the cellular
chromosome, thus explaining continued T antigen expression through
multiple cell generations? If so, did the interligation occur at a speciﬁc
site on the chromosome? Is there a speciﬁc viral mechanism to
facilitate integration, as is found in bacteriophage lambda?
Early studies looked for the presence of SV40 DNA in transformed
cells. The experimental approach was based on DNA hybridization
kinetics and was technically demanding. However, these experiments
clearly indicated that SV40 DNA was present through many genera-
tions of transformed cells (Sambrook et al., 1968; Westphal and
Dulbecco, 1968). Furthermore, viral early mRNA was present in SV40-
transformed cells (Khoury et al., 1973; Lee and Nathans, 1975; Ozanne
et al., 1973). The advent of Southern transfer and hybridization
methods allowed this issue to be examined at a much higher
resolution. SV40 transformed cells contain integrated SV40 DNA
(Botchan et al., 1976; Ketner and Kelly, 1976). The SV40 DNA is
integrated at random positions with respect to the cellular chromo-
somes. The exact integration site also appears to be random with
respect to viral DNA. However, SV40 integration in all transformed cell
lines is such that the SV40 early promoter and T antigen coding
sequences are intact, thus insuring continuous T antigen expression.
Large T antigen is essential for transformation
With the introduction of multiple new experimental tools
including restriction endonucleases, Southern and Northern hybridi-
zation, S1 nuclease and heteroduplex mapping, the genome organiza-
tion of SV40 was gradually revealed. The map was centered by ori, the
64 bp minimal origin of viral DNA replication. The T antigen gene, or A
gene, encompassed roughly half the DNA, and was expressed early
after infection. The capsid proteins were encoded by the late region, a
unit expressed after the onset of viral DNA replication.
Two lines of evidence were used to establish that T antigen
function is necessary for transformation. First, restriction endonu-
clease fragments of SV40 DNA containing the early region are
sufﬁcient for transformation, while shorter fragments or fragments
encoding the late region do not transform (Graham and van der Eb,
1973). Second, temperature-shift experiments with SV40 ts mutants
showed that A gene function is required to maintain transformation
(Brockman, 1978; Brugge and Butel, 1975; Kimura and Itagaki, 1975;
Martin and Chou, 1975; Noonan et al., 1976; Osborn and Weber, 1975;
Tegtmeyer, 1975).
Studies of revertants of SV40-transformed cell lines enforced the
notion that T antigenwas essential for transformation, and provided a
clear demonstration that the multiple properties of SV40-transformed
cells were not always coordinately displayed (Vogel and Pollack, 1973;
Vogel et al., 1973). Experiments that examined the properties of SV40-
transformed lines that were obtained without any phenotypic
selection also enforced this point (Risser and Pollack, 1974). These
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subset of the transformed phenotype.
The discovery of small t antigen had to await the development and
reﬁnement of several techniques: S1 protection and heteroduplex
mapping techniques so that splicing could be discovered, DNA
sequencing to obtain the early region open reading frames, and
immunological reagents, particularly monoclonal antibodies, that
recognized the T antigens. Mutants of large T antigen but not small t
antigen were used to show that small t antigen does not transform
when expressed alone, but does contribute to transformation under
some conditions (Bouck et al., 1978; Seif andMartin,1979; Shenk et al.,
1976; Sleigh et al., 1978).
Large T antigen: genetic analysis of a multifunctional protein
Three developments greatly speeded the genetic analysis of SV40,
and speciﬁcally of large T antigen: DNA sequencing, site-directed
mutagenesis, and the ability to insert the SV40 genome into bacterial
plasmid vectors. SV40 was the second genome to be completely
sequenced (Fiers et al., 1978; Reddy et al., 1978). The availability of the
sequence not only provided the ﬁrst view of a self-replicating genetic
unit in eukaryotes, but also proved a boon for the genetic analysis of
the virus, and particularly T antigen. The effect of mutations on protein
primary structure could now be determined. The contributions of
individual nucleotides to the functions of cis acting elements, such as
ori, the promoters, or the transcriptional enhancer could be assessed.
The development of methods allowing site-directed mutagenesis,
again using SV40 as the target, was the next key armament (Shortle
and Nathans, 1978). Now mutations could be speciﬁcally designed to
test speciﬁc hypotheses or to facilitate genetic screens. T antigenwas a
principal target, and the initial genetic assault focused on learning
how a single protein controlled multiple aspects of the virus life cycle
including both viral DNA replication and transformation.
The problem was that since T antigen is required for viral DNA
replication, many T antigen mutants were defective for virus
propagation. Thus, there was no easy way to generate stocks of
these mutants. Nonetheless, heroic efforts were made. One approach
was to introduce small deletionmutations into the T antigen gene, and
then propagate them by coculture with an SV40 mutant carrying a
large deletion in the late region. These mutations could complement
in trans and thus a mixed viral stock could be obtained. Virions
carrying the relatively small T antigen deletion could then be
separated from virions carrying the larger late region mutation by
CsCl buoyant density centrifugation (Scott et al., 1976).
This period of SV40 genetics deﬁned a new paradigm in genetics.
Mutate the DNA and screen for a phenotype, rather than the
traditional screen for a phenotype and then map the mutation to
the DNA. This, in fact, was the original meaning of “reverse genetics.”
Many new mutations were generated throughout the SV40 genome
(Carbon et al., 1975; Cole et al., 1977; Lai and Nathans, 1974a; Mertz
and Berg, 1974; Shenk et al., 1976). These new mutants were added to
the already existing collection of temperature-sensitive mutants,
which were now sequenced (Loeber et al., 1989). The development of
techniques that allowed the microinjection of DNA and proteins into
cells provided another avenue for assessing the biological activity of T
antigen truncations (Galanti et al., 1981). Still another tool in the
genetic analysis of SV40 came from the study of super-T antigens
(Lovett et al., 1982; May et al., 1981, 1983).
Perhaps the most bizarre, yet most powerful genetic tool utilized
during this period was the collection of human adenovirus-SV40
hybrids. Some types of human adenoviruses are defective for growth
in monkey cells. In order to facilitate vaccine production, attempts
were made to select for variants of these human adenovirus strains
that could be propagated in monkey cells. Stocks of human
adenoviruses were in fact obtained by passage through monkey
cells. These stocks fell into two broad categories, both of which hadunusual properties. Some stocks consisted of human adenovirus in
mixed culture with SV40. It turns out that human adenoviruses can
grow in monkey cells so long as these cells are coinfected with SV40.
This activity of SV40 is carried by T antigen, and speciﬁcally maps to a
carboxy-terminal domain called the HR domain (Cole et al., 1979;
Pipas, 1985).
This ﬁrst class of stocks was not of use for studying T antigen
functions, but the second class proved incredibly useful. These stocks
consisted only of human adenovirus virions. However, a fragment of
SV40 DNAwas integrated into a region of the adenovirus genome that
is not essential for growth in cell culture. Different adenovirus isolates
harbored different amounts of SV40 DNA, and these hybrid viruses
were used to map the SV40 genome (Kelly and Lewis, 1973; Lebowitz
et al., 1974; Lewis et al., 1974; Lewis and Rowe, 1973; Morrow et al.,
1973). All of these adenovirus-SV40 hybrids carried a portion of the T
antigen gene expressed as a fusion protein. All of the T antigen
fragments contained an intact carboxy-terminal region of the protein,
but were missing various amounts of the amino-terminal portion.
Thus, as a collection they provided a set of T antigen deletion that
expressed various sized carboxy-terminal fragments. The shortest
piece of T antigen found in one of these isolates encoded just the last
38 amino acids of T antigen. Thus, the adenovirus-helping function of
T antigen resides in this small carboxy-terminal fragment. The exact
function of this T antigen domain is still unclear today.
The discovery and characterization of viable adenovirus-SV40
hybrids uncovered a paradigm directly relevant to emerging infectious
diseases, which remains underappreciated today. The principle is that
nonhomologous recombination across virus families can result in a
virus with an extended host-range. Does this type of genetic exchange
occur in nature, and if so, does it represent amechanism bywhich new
viruses can arise?
The ﬁnal tool needed to accelerate the genetic analysis of SV40 was
the demonstration that the SV40 genome could be cloned and
propagated in bacteria as a recombinant plasmid, and rescued from
that plasmid to regenerate infectious SV40 virions (Peden et al., 1980).
This same paper included the ﬁrst demonstration that oncogenes, in
this case the SV40 T antigens, can induce transformation when
expressed from a plasmid that had been propagated in bacteria. With
the advent of cloning, T antigen mutants that were defective for virus
growth could be ampliﬁed in bacteria prior to study in mammalian
cells.
The availability of this collection of genetic tools drove a detailed
dissection of T antigen's various activities. Different functions were
mapped to distinct positions on T antigen's primary sequence. During
this process a large number of truncation and amino acid substitution
mutants were generated that screened for function (Clark et al., 1983;
Kalderon et al., 1982; Kalderon and Smith, 1984; Peden and Pipas,
1992; Pipas et al., 1980, 1983; Soprano et al., 1983). The characteriza-
tion of these mutants led to our current view of T antigen structure.
Large T antigen consists of four structural domains: a J domain at the
amino-terminus, a sequence speciﬁc DNA binding domain (OBD), a
zinc binding domain, and ﬁnally an ATPase domain. The structure of
each of these domains has been obtained (Kim et al., 2001; Li et al.,
2003; Luo et al., 1996). The J domain is connected to the OBD by a
relatively unstructured linker that contains docking sites for several
cellular proteins. The structure of the HR/Ad helper domain at the
carboxy-terminus has not been solved, nor is there yet a structure for
the intact protein. Therefore, we know little about the orientation of
one domain relative to another, nor of the dynamics that govern their
movement. The structure of the complete small t antigen has been
solved (Cho et al., 2007). Like large T antigen, small t antigen has a J
domain at its amino-terminus, followed by a uniquely structured
domain that governs its interaction with the cellular phosphatase,
pp2A.
Several important conclusions were reached regarding T antigen's
transforming functions based on genetic studies. First, the large T
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conserved LXCXEmotif located in the linker between the J domain and
OBD, are both essential for transformation (Figge et al., 1988; Montano
et al., 1990; Peden and Pipas, 1992; Pipas et al., 1983). Interestingly, a
transformation-defective mutant mapping to the large T/small t
common region can be complemented by the adenovirus E1A protein
(Yaciuk et al., 1991). Second, sequences in the carboxy-terminal half of
T antigen are required for transformation (Pipas et al., 1983; Zhu et al.,
1992). Thus, T antigen possesses multiple activities that contribute to
transformation (Dickmanns et al., 1994; Srinivasan et al., 1989).
Furthermore, in some circumstances both the amino-terminal
transforming sequences and the carboxy-terminal transforming
function were required in concert to induce transformation, while
under other conditions the amino-terminal functions were sufﬁcient
(Clayton et al., 1982; Colby and Shenk, 1982; Slinskey et al., 1999;
Sompayrac and Danna, 1983; Srinivasan et al., 1989).
Another important result of this period was the identiﬁcation of T
antigen mutants that appear to separate different properties of the
transformed phenotype. It was known that T antigen expression was
sufﬁcient to transform cells by several assays including immortaliza-
tion, dense focus formation, anchorage independent growth and
tumorigenicity in animals. Two models were considered to explain
how this single viral protein altered somany cellular properties. In one
model, T antigen functions as a pleiotropic effector. That is, all of the
properties of a transformed cell are simultaneously acquired because T
antigen acts on a key cellular target, and this key cellular regulator
controls all of the phenotypes. Alternatively, T antigen could
independently act on multiple targets, each regulating one cellular
property. The observation that immortalization can be separated
genetically from the induction of dense foci, and the ﬁnding that the
induction of anchorage independent growth is genetically separable
from tumorigenicity strongly supported the latter model (Tevethia et
al., 1988; Thompson et al., 1990).
The intense focus on SV40 genetics and transformation, coupled
with the availability of newmolecular methods, led to many advances
in cell biology tangentially related to transformation. These include
the development of methods for mapping CTL recognition sites on T
antigen (Anderson et al., 1988; Tanaka et al., 1988; Tevethia, 1983); the
ﬁrst description of non-homologous end-joining, or NHEJ (Wilson et
al., 1982); and the discovery of the nuclear localization signal (Butel et
al., 1969; Kalderon et al., 1984a, 1984b; Lanford and Butel, 1984). These
genetic studies set the stage for uncovering the mechanisms by which
SV40 induces cell transformation.
The relationship between viral replication and cellular
transformation
The early observation that T antigen was required for both viral
DNA replication and for the stimulation of cellular DNA synthesis led
to a model for SV40 transformation. This model assumed that the
mechanism that T antigen uses to initiate and drive viral DNA
replication also applies to cellular DNA. Perhaps T antigen acted on
cellular origins of replication, much as it does on the viral ori, and all
the properties of a transformed cell are the downstream consequence
of driving cells into S phase. This idea was supported by experiments
showing that SV40 transformed cells have more replication origins
than normal cells (Martin and Oppenheim, 1977).
A clear prediction of this model is that T antigen mutants that are
defective for viral DNA replication should also be defective for
stimulating cellular DNA synthesis and transformation. This ﬁt with
observations using temperature-sensitive mutants, since both viral
DNA replication and transformation were lost at the nonpermissive
temperature. However, the isolation of replication-defective T antigen
mutants that retained the ability to transform clearly indicated that
this model could not be correct (Gluzman and Ahrens, 1982; Kalderon
and Smith, 1984; Manos and Gluzman, 1984, 1985; Peden and Pipas,1985; Stringer, 1982). The description of the widely used COS cell line,
a permissive monkey cell line expressing wild-type T antigen
stemmed from these studies (Gluzman, 1981). Furthermore, mutants
that retained the ability to replicate viral DNA, but were transforma-
tion-defective, were also obtained (Cosman and Tevethia, 1981; Peden
et al., 1990).
SV40 induces transformation by binding key cellular proteins and
altering their activities
The availability of high quality antibodies that speciﬁcally
immunoprecipitated T antigen from cell extracts led to the develop-
ment of combined genetic and proteomic approaches. These
approaches were greatly enhanced by a collection of monoclonal
antibodies speciﬁc for the SV40 T antigens (Harlow et al., 1981;
Montano and Lane, 1984). These reagents set the stage for the
discovery of cellular proteins that associate with the T antigens in
infected or transformed cells. The combination of immunoprecipita-
tion experiments with mutational analysis led to the identiﬁcation of
two critical targets that T antigen must act on to elicit transformation,
the tumor suppressors p53 and pRb. Other chapters in this volume
describe the details of these experiments. The salient points are
summarized here.
T antigen–p53 complexes were identiﬁed both in SV40-trans-
formed and infected cells (Lane and Crawford,1979; Linzer and Levine,
1979). Furthermore, T antigen mutants defective for p53 binding are
also transformation defective (Kierstead and Tevethia, 1993; Peden et
al., 1989,1998; Zhu et al., 1991).While the association of Tantigenwith
p53 is necessary for transformation, it is not sufﬁcient (Conzen and
Cole, 1995). The interaction of T antigen with p53 blocks p53-
dependent gene expression. This is partially due to the fact that T
antigen binding blocks DNA binding by p53, thus it cannot associate
with its target promoters (Bargonetti et al., 1992; Lilyestrom et al.,
2006). Apparently T antigen also can block p53-dependent transcrip-
tion and growth-arrest by mechanisms that are independent of direct
association (Gjoerup et al., 2000; Quartin et al., 1994; Rushton et al.,
1997). The interaction of T antigen and p53 also blocks T antigen's
replicative functions (Lilyestrom et al., 2006; Tack et al., 1989;Wang et
al., 1989). Under normal circumstances, p53 is unstable and does not
accumulate to signiﬁcant levels. However, as a consequence of its
interactionwith Tantigen, p53 is stabilized and Tantigen-transformed
cells contain abundant amounts of the protein.
Similarly, the interaction of T antigen with the Rb family of
proteins, pRb, p107 and p130, is essential for transformation (Chen
and Paucha, 1990; DeCaprio et al., 1988; Ewen et al., 1989; Ludlow et
al., 1989, 1990). In fact, it appears that all polyomavirus-encoded large
T antigens interact with Rb proteins through their conserved LXCXE
motif (Dyson et al., 1990). The current model is that T antigen must
block the growth-suppressive functions of all three Rb proteins in
order to induce transformation. This is consistent with the observation
that the T antigen LXCXE motif is not required to transform cells in
which an upstream negative regulator of the Rb proteins has been
ablated, or that are lacking Rb proteins (Chao et al., 2000; Zalvide and
DeCaprio, 1995). Interestingly, when the LXCXE motif is moved to the
carboxy-terminus of T antigen, transformation is not affected
(Tevethia et al., 1997b).
As discussed above, the third region of T antigen that is essential
for transformation is the amino-terminal domain it shares with small t
antigen. This region is a J domain, and T antigen functions as a DnaJ
molecular chaperone (Srinivasan et al., 1997). The Tantigen J domain is
required to inactivate Rb proteins and, thus for transformation
(Srinivasan et al., 1997; Stubdal et al., 1997; Zalvide et al., 1998). The
function of the J domain is to recruit the cellular hsc70 chaperone
protein so that energy derived from hsc70-mediated ATP hydrolysis
can be used to disrupt the association of Rb proteins with E2F
transcription factors (Sullivan et al., 2000, 2001). This model is
299Minireviewconsistent with the structure of a T antigen fragment with pRb (Kim et
al., 2001).
These efforts established that interaction of T antigen with three
cellular targets contribute to transformation. The interaction of T
antigen with hsc70 and the Rb proteins is required to free E2Fs from
Rb-mediated repression, thus driving cells into S phase, while its
interaction with p53 blocks this tumor suppressor's growth-repres-
sive and proapoptotic functions. This model leaves a major discre-
pancy unresolved: how does this reconcile with earlier observations
that both the amino-terminal half and the carboxy-terminal half of T
antigen can independently induce transformation under some
circumstances? This question will be discussed further below.
While the inactivation of Rb proteins and of p53 is essential for
transformation, a number of studies indicate that these actions are not
sufﬁcient (Manfredi and Prives, 1990; Sachsenmeier and Pipas, 2001).
Does SV40 act on additional cellular targets to elicit transformation?
Several additional potential targets of T antigen have been identiﬁed
(for a review, see Ahuja et al., 2005). Clearly small t antigen's action on
the cellular phosphatase pp2A is required for transformation in some
cases (Hahn et al., 2002; Pallas et al., 1990). In addition, large T antigen
interactions with CBP/p300, TEF-1, Cul7, and Bub1 have been
implicated in transformation (Ali et al., 2004; Berger et al., 1996;
Borger and DeCaprio, 2006; Eckner et al., 1996; Hein et al., 2008;
Kasper et al., 2005; Lill et al., 1997; Poulin et al., 2004). Finally, the IGF
pathway has been reported to play a role in SV40 transformation
(DeAngelis et al., 2006; Fei et al., 1995; Porcu et al., 1992; Sell et al.,
1993). How these interactions contribute speciﬁcally to the trans-
formed phenotype is the subject of current investigations.
Combining mouse and viral genetics: how does SV40 action on
cellular targets contribute to tumorigenesis?
SV40 T antigen was the ﬁrst viral oncoprotein to be expressed in
transgenic mice and the fact that these mice developed neoplasia of
the choroid plexus opened the door to speciﬁc phenotypes displayed
in cell culture to tumorigenesis in animals (Brinster et al., 1984).
Among the ﬁrst mutants to be tested was dl1137, a deletion mutation
that expresses the ﬁrst 121 amino acids of T antigen fused to 11
missense amino acids followed by a premature stop codon. The
resulting T antigen fragment includes the J domain and the LXCXE
motif, but terminates just short of the NLS. This mutant had been
shown to stimulate cellular DNA synthesis and transform some
established cell lines (Soprano et al., 1983; Srinivasan et al., 1989). Two
other mutants were also studied: one carrying an amino acid
substitution in the LXCXE motif that renders it unable to associate
with Rb proteins, while the other carries an in-frame deletion that
inactivates the J domain, but is capable of binding Rb proteins and p53.
These studies established that both the J domain and LXCXE motif
were required to induce choroid plexus neoplasia (Chen et al., 1992;
Saenz Robles et al., 1994; Symonds et al., 1993).
These studies conﬁrmed that in the mouse, as in cell culture, the J
domain and Rb-binding functions of T antigen were required for
transformation. Results obtained with the mutant dl1137 were more
intriguing and established an important paradigm of tumorigenesis
(Saenz Robles et al., 1994; Symonds et al., 1993). This mutant induced
choroid plexus neoplasia, but the tissue expanded much slower than
seen with full-length T antigen. The number of proliferating cells was
identical as that seen in transgenic mice expressing full-length T
antigen. Furthermore, while little or no apoptosis was apparent in the
choroid plexus expressing wild-type T antigen, abundant apoptosis is
detected in dl1137 transgenic mice. Thus, the rate of tissue expansion
is controlled by the balance of two factors, cell proliferation and cell
death. Expression of dl1137 in p53 null mice results in rapidly growing
tumors showing little apoptosis. Thus, the increased cell death seen in
the dl1137 transgenic mice was due to this protein's inability to block
p53. The dl1137 mutant, renamed T121, induces cell proliferation in anumber of different mouse tissues showing that this effect is not
limited to the choroid plexus (Simin et al., 2004).
When T antigen is expressed in the enterocytes of the mouse small
intestine, these terminally differentiated cells are driven back into the
cell cycle resulting in intestinal hyperplasia (Kim et al., 1994). The
mutant N136 expresses the ﬁrst 136 amino acids of T antigen, which
includes the J domain, LXCXE motif, and NLS and no missense amino
acids, and also induces intestinal hyperplasia. Furthermore, both the
LXCXE motif and the J domain are required to induce enterocyte
proliferation (Kim et al., 1994; Rathi et al., 2007). Thus, unlike the
choroid plexus, the inactivation of Rb proteins does not induce a p53
response, and T antigen–p53 interactions play no role in the
transformation of this cell type (Markovics et al., 2005). Similar
results were obtained in the pancreas, where T antigen's ability to
induce tumors is independent of its ability to bind p53 (Tevethia et al.,
1997a).
This simple system allows a direct test of an important part of the
SV40 transformation model. The model predicts that, as a conse-
quence of Rb protein inactivation, E2Fs are freed to drive gene
expression and cell proliferation. Thus, T antigen-mediated transfor-
mation should require E2F-dependent transcription. This prediction
has been difﬁcult to test in cell culture systems because of the
functional redundancy of multiple E2Fs. However, in many tissue
settings only a few or even a single E2F are expressed. Two major
activating E2Fs, E2F2 and E2F3a, are induced upon expression of T
antigen in enterocytes and their ablation greatly reduces T antigen-
induced enterocyte proliferation (Saenz-Robles et al., 2007).
Studies fromboth transgenic andcell culture systems established that
T antigen possesses at least two functions, Rb-inactivation and p53
inactivation, that contribute to transformation. In many instances, these
functions cooperate to induce transformation. Similarly, different cellular
oncogenes cooperate to transform cells (Land et al., 1983; Ruley, 1983).
Both wild-type T antigen and the amino-terminal truncation mutants,
such as dl1137, cooperate with the cellular oncogene ras to induce
transformation (Michalovitz et al., 1987; White et al., 1992). In fact, T
antigen possesses two independent activities, each of which can
cooperate with ras (Beachy et al., 2002; Cavender et al., 1995).
Where are we now?
As of this date, our understanding of how SV40 induces
transformation in cell culture and tumors in animals is incomplete.
However, a number of the pieces of the puzzle are in place and the
immediate questions are fairly clear. T antigen drives cells into the cell
cycle by its action on the Rb proteins: pRb, p107, and p130. Quiescence
is maintained, in part, by the presence of a repressive complex on the
promoters of E2F-responsive genes. This complex, termed DREAM, is
anchored on these promoters by E2F4, which directly binds to DNA,
and p130, that is bound to E2F4. T antigen binds to E2F4 via its LXCXE
motif and, in a reaction that requires hsc70-mediated ATP hydrolysis,
destroys the repressive complex by dislodging E2F from p130, and
sending p130 to the proteasome for degradation. This results in the
derepression of E2F1, E2F2, and E2F3a, the activating E2Fs, that then
bind to these same promoters and stimulate gene expression and S
phase entry. This explains early observations that amino-terminal
fragments of T antigen, as short as 121 amino acids, are capable of
stimulating cellular DNA synthesis. This model also explains why
truncated T antigens induce neoplasia in transgenic mice. However,
we cannot yet conclude that T antigen action on Rb proteins is
sufﬁcient for these effects. The amino-terminal fragments encoded by
dl1137 and N136 also contain binding sites for Cul7 and Bub1, both of
which have been implicated in SV40 transformation. Thus, it is
possible that T antigen action on these, or other yet to be discovered,
targets is also required for transformation.
In many cell-types, the unscheduled stimulation of S phase
resulting from Rb protein inactivation results in the activation of the
300 Minireviewp53 pathway. The stabilization of p53 and subsequent transcription of
p53-dependent genes results in cell cycle arrest and/or apoptosis. T
antigen blocks this response by binding to p53 and preventing p53-
dependent transcription. However, this may only be part of the story.
As a consequence of its interaction with T antigen, p53 is stabilized
and SV40-transformed cells contain large amounts of T antigen–p53
complexes. It is possible that these complexes contribute to some
aspect of transformation, a so-called gain of function model. For
example, the transcriptional adapter proteins CBP and p300 are
recruited to T antigen–p53 complexes via their interaction with p53.
One possibility is that the indirect interaction of T antigen with CBP/
p300 plays some role in transformation, as it does with the adenovirus
E1A protein.
Finally, a number of lines of evidence indicate that T antigen action
on the Rb proteins and on p53 is not sufﬁcient for transformation. A
number of potential additional targets have been discussed above.
One of the next challenges is to understand how these different T
antigen actions are coordinated to induce the transformed phenotype.
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